Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 176 of the 177 references it cites were found in a registry or an index; 17 of the 166 sources its claims cite were checked for support.

The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes

Open access
Kahn, S. E. · 2003 · Diabetologia

Abstract

The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes have been debated extensively. The concept that a feedback loop governs the interaction of the insulin-sensitive tissues and the beta cell as well as the elucidation of the hyperbolic relationship between insulin sensitivity and insulin secretion explains why insulin-resistant subjects exhibit markedly increased insulin responses while those who are insulin-sensitive have low responses. Consideration of this hyperbolic relationship has helped identify the critical role of beta-cell dysfunction in the development of Type 2 diabetes and the demonstration of reduced beta-cell function in high risk subjects. Furthermore, assessments in a number of ethnic groups emphasise that beta-cell function is a major determinant of oral glucose tolerance in subjects with normal and reduced glucose tolerance and that in all populations the progression from normal to impaired glucose tolerance and subsequently to Type 2 diabetes is associated with declining insulin sensitivity and beta-cell function. The genetic and molecular basis for these reductions in insulin sensitivity and beta-cell function are not fully understood but it does seem that body-fat distribution and especially intra-abdominal fat are major determinants of insulin resistance while reductions in beta-cell mass contribute to beta-cell dysfunction. Based on our greater understanding of the relative roles of insulin resistance and beta-cell dysfunction in Type 2 diabetes, we can anticipate advances in the identification of genes contributing to the development of the disease as well as approaches to the treatment and prevention of Type 2 diabetes.

Overview

CoChat Summary

TL;DR

This review argues that insulin resistance and beta-cell dysfunction are both present early in the natural history of Type 2 diabetes, and that beta-cell function must be interpreted relative to insulin sensitivity through the hyperbolic/disposition-index relationship. It concludes that progressive beta-cell failure is a major determinant of worsening glucose tolerance, while intra-abdominal fat is a key determinant of insulin resistance.

Key findings

  • The relationship between insulin sensitivity and insulin secretion is non-linear and best described as hyperbolic; the product of insulin sensitivity and insulin response (disposition index) is constant for a given degree of glucose tolerance. This was shown in 93 healthy subjects younger than 45 years and confirmed in Danish and Pima Indian cohorts.
  • In 531 first-degree relatives of Type 2 diabetic subjects from four ethnic groups, beta-cell function adjusted for insulin sensitivity accounted for 45% of the variance in glucose disposal, compared with 8% for insulin sensitivity alone and 29% for the early insulin response alone. Among subjects with normal glucose tolerance, those with poorer glucose disposal had reduced beta-cell function but no difference in insulin sensitivity.
  • In Pima Indians followed for an average of 5 years, those progressing to diabetes had a 78% decline in insulin secretion while insulin sensitivity decreased by only 14%; non-progressors had an 11% decrease in insulin sensitivity accompanied by a 30% increase in insulin secretion.
  • Intra-abdominal fat was the strongest correlate of insulin sensitivity, explaining 47% of its variance in 174 subjects. Prevention trials cited include DPP lifestyle intervention reducing diabetes development by 58% and metformin by 31%, STOP-NIDDM acarbose by 25%, and TRIPOD troglitazone by 55%; in UKPDS, after 9 years only 25% of the intensive-treatment arm achieved HbA1c below 7% with monotherapy.

Methods

  • Narrative review based on English-language literature published during 1990–2001 and seminal prior contributions, integrated with PubMed searches for “insulin resistance, diabetes and humans” and “insulin secretion, diabetes and humans.”
  • Synthesizes cross-sectional and longitudinal human studies, including a 174-subject cohort (73 men/101 women, age 30–75 years), 531 first-degree relatives from four ethnic groups, and Pima Indian follow-up data; no new primary data are reported.

Limitations

  • Stated: the genetic and molecular basis for reductions in insulin sensitivity and beta-cell function are not fully understood; the mechanism(s) by which body-fat distribution influences insulin sensitivity are unclear; whether beta-cell regulation is governed by a central neural process or a humoral signal is unknown; and mechanisms by which lifestyle or metformin reduced diabetes development in prevention studies had not yet been reported.
  • Stated: at the time of writing, no known pharmacological intervention was capable of preventing the progressive decline in beta-cell function in Type 2 diabetic patients.
  • Evident: as a narrative review, it does not use a systematic search or meta-analysis and relies on heterogeneous observational and intervention studies, limiting causal inference.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1007/s00125-002-1009-0

Cites

176 of 176 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

14 Valid · 1 Not valid · 64 Not checked · 42 Own results and interpretations

66 more claims · 7 with their cited sources checked

Create a free account to see all 121 claims and to verify the 149 references still open.

See all claims — free account
  • It may state two separate claims as one. 47
  • Probably not a substantial claim. 2
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 177 references

Research works printed but not linked: 2

  1. Kahn SE (1996) Regulation of B-cell function in vivo: from health to disease. Diabetes Rev 4:372–389
  2. Landchild MJ, Knowles NG, Yao Q et al. (2000) Increased β-cell secretory demand is not the simple explanation for inefficient proinsulin processing and islet amyloid formation in type 2 diabetes. J Investig Med 48:21A (Abstract)

Cited by

See all 2,166

Metadata

Authors
Kahn, S. E.
Affiliations
University of Washington (US)
Corresponding author
Kahn, S. E.
Venue
Diabetologia
Published
2003-01
Volume
46
Issue
1
Pages
3-19
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W2004014076
Cited by
2,166
References
177
Citations by year
2026: 45 · 2025: 54 · 2024: 88 · 2023: 85 · 2022: 99 · 2021: 105 · 2020: 110 · 2019: 95 · 2018: 109 · 2017: 105 · 2016: 90 · 2015: 110 · 2014: 134 · 2013: 120 · 2012: 95
FWCI
13.10
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Diabetologia (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Veterans Affairs (DK-17047)
  • National Institutes of Health (RR-37)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK050703, K24DK002654, DK50703, DK 02654, DK-17047, P30DK017047)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
type 2 diabetes, insulin resistance, beta-cell dysfunction, insulin sensitivity, insulin secretion, hyperbolic relationship, beta-cell mass, intra-abdominal fat, body fat distribution, oral glucose tolerance, impaired glucose tolerance, genetic susceptibility, disease prevention
MeSH terms
Adipose Tissue, Diabetes Mellitus, Type 2, Humans, Insulin, Insulin Resistance, Islets of Langerhans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. https://app.cochat.ai/papers/10.1007/s00125-002-1009-0
The paper
Kahn, S. E. (2003). The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia. https://doi.org/10.1007/s00125-002-1009-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.